Albuminuria reflects widespread vascular damage - The Steno hypothesis

Diabetologia

Volumn 32, Issue 4, 1989, Pages 219-226

  Deckert, T ^a   Feldt Rasmussen, B ^a   Borch Johnsen, K ^a   Jensen, T ^a   Kofoed Enevoldsen, A ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

albuminuria; Diabetes; extracellular matrix; heparan sulphate; vascular dysfunction

Indexed keywords

HEPARAN SULFATE;

BLOOD VESSEL INJURY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

ALBUMINURIA; BIOLOGICAL MARKERS; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMAN; MODELS, THEORETICAL;

EID: 0024410794     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00285287     Document Type: Review

References (113)

1. The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus
2. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study
3. Urinary albumin excretion in early and long-term juvenile diabetes
4. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure
5. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy
6. Glomerular filtration surface in Type 1 diabetes mellitus
7. Clinical assessment and prognosis of complication of diabetes
8. Incidence of retinopathy in Type 1 (insulin-dependent) diabetes: Association with clinical nephropathy
9. Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria
10. Microalbuminuria and diabetic retinopathy
11. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: Proteinuria and retinopathy in a population of diabetic persons diagnosed prior to 30 years of age
12. Proteinuria — A predictor of cardiovascular mortality in insulin-dependent diabetes mellitus
13. The prognostic significance of proteinuria: the Frammingham Study
14. Microalbuminuria as predictor of vascular disease in non-diabetic subjects
15. Microalbuminuria is a strong predictor of 6-year mortality of elderly Type 2 (non-insulin-dependent) diabetic patients and non-diabetic subjects. Aprospective study
16. The effect of proteinuria on mortality in non-insulin-dependent diabetes mellitus
17. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients
18. Microalbuminuria predicts mortality in non-insulin-dependent diabetes
19. Cardiovascular risk factors in Type 1 (insulin-dependent) diabetic patients with and without proteinuria
20. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics
21. Tobacco and end stage diabetic nephropathy
22. Abnormalities in plasma concentration of lipoproteins and fibrinogens in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion
23. Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients
24. Metabolism of albumin and fibrinogen in Type 1 (insulin-dependent) diabetes mellitus
25. Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria
26. Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in Type 1 (insulin-dependent) diabetes mellitus
27. Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors
28. Permeability and morphology of skeletal muscle capillaries in Type 1 (insulin-dependent) diabetes mellitus
29. Regulation of extravascular coagulation by microvascular permeability
30. Fibrin induced release of von Willebrand factor from endothelial cells
31. Increased plasma level of von Willebrand factor in Type 1 (insulin-dependent) diabetic patients with incipient nephropathy
32. Evidence for functional endothelial cell damage in early diabetic retinopathy
33. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus
34. Angiotensin-converting enzyme (ACE): relationship to insulin dependent diabetes and microangiopathy
35. Serum angiotensin-converting enzyme: Elevations in diabetes mellitus
36. The changing natural history of nephropathy in Type 1 diabetes
37. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes
38. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
39. Evidence against increased glomerular pressure initiating diabetic nephropathy
40. Thoughts on the pathogenesis of diabetic nephropathy
41. Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations
42. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population
43. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus
44. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy
45. Raised arterial pressure in parents of proteinuric insulin dependent diabetics
46. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice
47. Changes of human glomerular basement membrane in diabetes mellitus
48. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes
49. Disturbances in glomerular basement membrane glycosaminogylcans in experimental diabetes
50. Relevance to pathogenesis and prevention of diabetic nephropathy
51. Studies on glomerular basement membrane in experimental diabetes using lectin histochemistry in Wistar rats
52. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition
53. Influence of charge on filtration across renal basement membrane films in vitro
54. Characterization of heparan sulfate-proteoglycan of glomerular basement membranes
55. Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus
56. Evidence of changes in renal charge selectivity in patients with Type 1 (insulin-dependent) diabetes mellitus
57. Improved metabolic control does not alter the charge-dependent glomerular filtration of albumin in uncomplicated Type 1 (insulin-dependent) diabetes
58. Charge heterogeneity of glycated human serum albumin
59. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus
60. Charge selectivity of proteinuria in diabetic glomerulopathy
61. Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy
62. Glomerular capillary wall dysfunction in progressive diabetic nephropathy
63. Cytochemical studies of the anionic changes in the kidney in Type 1 diabetes mellitus
64. Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane
65. Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes
66. Abnormal erythrocyte charge in diabetes mellitus
67. Reduced negative surface charge on arterial endothelium of diabetic rats
68. Presence of heparan sulfate in glomerular basement membrane
69. Glycosaminoglycans of arterial basement membrane-like material from cultured rabbit aortic myomedial cells
70. Distribution of sulfated glycosamingoglycans in the glomerular basement membrane and mesangial matrix
71. Effect of p-Nitrophenyl-β-D-xyloside on proteoglycan synthesis and extracellular matrix formation by bovine corneal endothelial cell cultures
72. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin
73. Changes in heparan sulfate correlate with increased glomerular permeability
74. Anionic sites and the mechanisms of proteinuria
75. Structure and function of heparan sulphate proteoglycans
76. Molecular mechanisms in basement membrane complications of diabetes
77. Acute reversible proteinuria induced by infusion of the polycation hexadimethrine
78. Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation
79. N-desulfated/acetulated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation
80. Acceleration of thrombin-antithrombin complex formation rat hindquarters via heparin-like molecules bound to the endothelium
81. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate progeoglycan
82. Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans
83. Microvascular heparin-like species with anticoagulant activity
84. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats
85. Platelet aggregation and coagulation factors in insulin dependent diabetics with and without microangiopathy
86. Platelet-derived growth factor: structure, function and roles in normal and transformed cells
87. Production of platelet-derived growth factor-like protein by Rat Mesangial cells in culture
88. Platelet-inhibitor treatment of diabetic nephropathy: A 10-year prospective study
89. Heparan sulphate and the binding of lipoprotein lipase to porcine thoracic aorta endothelium
90. Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats
91. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells
92. Diabetic macroangiopathy
93. In vivo transfer of cholesterol from plasma into human aortic tissue
94. Recent advances in molecular pathology
95. Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence
96. Biosynthesis and structure of the basement membrane proteoglycan containing heparan sulphate side-chains
97. Glycosaminogylcans and their binding to biological macromolecules
98. Subcellular localization of the sulphation reaction of heparan sulphate synthesis and transport of the proteoglycan to the cell surface in rat liver
99. Biosynthesis of heparin
100. Reduced sulfation of liver heparan sulfate in experimentally diabetic rats
101. Sulfate metabolism in the alloxan-diabetic rat: relationship of altered sulfate pools to proteoglycan sulfation in heart and other tissues
102. Glomerular proteoglycans in diabetes
103. Evidence for diabetes-induced alterations in the sulfation of heparan sulfate in intestinal epithelial cells
104. Structural-functional relationships in diabetic nephropathy
105. Features of endothelial dysfunction in early diabetic nephropathy